Elisa de Lazzari

ORCID

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 8

Top Venues

The Journal of antimicrobial chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Elisa de Lazzari, Eugenia B Negredo, Pere Domingo, Juan Manuel Tiraboschi, Esteve Ribera, Nadia Abdulghani, Verònica Alba, Salvador Fernández-Arroyo, Consuelo Viladés, Joaquim Peraire, Jose M Gatell, Jose L Blanco, Francesc Vidal, Anna Rull, Esteban Martinez
Multiomics plasma effects of switching from triple antiretroviral regimens to dolutegravir plus lamivudine. The Journal of antimicrobial chemotherapy 79 (5) (2024)
Iván Chivite, Leire Berrocal, Elisa de Lazzari, Soodabeh Navadeh, Carla Lluis-Ganella, Alexy Inciarte, Lorena de la Mora, Ana González-Cordón, Maria Martínez-Rebollar, Montserrat Laguno, Berta Torres, José Luis Blanco, Esteban Martinez, Josep Mallolas, Juan Ambrosioni
Effectiveness, safety and discontinuation rates of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) in people with HIV using real-world data: a systematic review and meta-analysis. The Journal of antimicrobial chemotherapy 79 (8) (2024)
Iván Chivite, Leire Berrocal, Elisa de Lazzari, Soodabeh Navadeh, Carla Lluis-Ganella, Alexy Inciarte, Lorena de la Mora, Ana González-Cordón, Maria Martínez-Rebollar, Montserrat Laguno, Berta Torres, José Luis Blanco, Esteban Martinez, Josep Mallolas, Juan Ambrosioni
Effectiveness, safety and discontinuation rates of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) in people with HIV using real-world data: a systematic review and meta-analysis. The Journal of antimicrobial chemotherapy (2024)
Elisa de Lazzari, Eugenia B Negredo, Pere Domingo, Juan Manuel Tiraboschi, Esteve Ribera, Nadia Abdulghani, Verònica Alba, Salvador Fernández-Arroyo, Consuelo Viladés, Joaquim Peraire, Jose M Gatell, Jose L Blanco, Francesc Vidal, Anna Rull, Esteban Martinez
Multiomics plasma effects of switching from triple antiretroviral regimens to dolutegravir plus lamivudine. The Journal of antimicrobial chemotherapy 79 (5) (2024)
Elisa de Lazzari, Eugenia B Negredo, Pere Domingo, Juan Manuel Tiraboschi, Esteve Ribera, Nadia Abdulghani, Verònica Alba, Salvador Fernández-Arroyo, Consuelo Viladés, Joaquim Peraire, Jose M Gatell, Jose L Blanco, Francesc Vidal, Anna Rull, Esteban Martinez
Multiomics plasma effects of switching from triple antiretroviral regimens to dolutegravir plus lamivudine. The Journal of antimicrobial chemotherapy 79 (5) (2024)
Elisa de Lazzari, Eugenia B Negredo, Pere Domingo, Juan Manuel Tiraboschi, Esteve Ribera, Nadia Abdulghani, Verònica Alba, Salvador Fernández-Arroyo, Consuelo Viladés, Joaquim Peraire, Jose M Gatell, Jose L Blanco, Francesc Vidal, Anna Rull, Esteban Martinez
Multiomics plasma effects of switching from triple antiretroviral regimens to dolutegravir plus lamivudine. The Journal of antimicrobial chemotherapy 79 (5) (2024)
Elisa de Lazzari, Eugenia B Negredo, Pere Domingo, Juan Manuel Tiraboschi, Esteve Ribera, Nadia Abdulghani, Verònica Alba, Salvador Fernández-Arroyo, Consuelo Viladés, Joaquim Peraire, Jose M Gatell, Jose L Blanco, Francesc Vidal, Anna Rull, Esteban Martinez
Multiomics plasma effects of switching from triple antiretroviral regimens to dolutegravir plus lamivudine. The Journal of antimicrobial chemotherapy (2024)
Elisa de Lazzari, Eugenia B Negredo, Pere Domingo, Juan Manuel Tiraboschi, Esteve Ribera, Nadia Abdulghani, Verònica Alba, Salvador Fernández-Arroyo, Consuelo Viladés, Joaquim Peraire, Jose M Gatell, Jose L Blanco, Francesc Vidal, Anna Rull, Esteban Martinez
Multiomics plasma effects of switching from triple antiretroviral regimens to dolutegravir plus lamivudine. The Journal of antimicrobial chemotherapy 79 (5) (2024)

Elisa de Lazzari.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Elisa de Lazzari